Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-10

Study Completion Date

2018-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was designed to explore an alternative approach to reduce weight in human beings using a polyherbal formulation. A polyherbal formulation named as Obesecure was developed after screening of local medicinal flora. The formulation was further improved after pilot studies and Phase-I Clinical Trials.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Fenugreek and Cumin Powder on Overweight and Obese People

NCT05966935

Overweight and Obesity

COMPLETED NA

A Comparison Between the Effects of Conventional Diets vs Intermittent Fasting Diabetic and Pre-diabetic Patients

NCT04463277

Diabetes Mellitus, Type 2 PreDiabetes

COMPLETED NA

Effect of Cinnamon Powder Capsules on Body Composition

NCT06119555

Body Composition

RECRUITING NA

Effect of Pomegranate Seed Powder on Markers of Metabolic Syndrome

NCT05944029

Metabolic Syndrome

UNKNOWN NA

The Effects of Glucomannan on Weight Loss

NCT01709955

Obesity

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Obesity is a common disease of developing countries including Pakistan. Obesity is a risk factor for many diseases which can be life-threatening or making the person unable to perform daily routine work. Obesity is considered a risk factor for different diseases like cardiovascular diseases, hormonal imbalance, infections, malignancies and chest problems. The leptin hormone has appetite suppressing and energy dissipation activity in the body. A screening study on animals was carried out to find out the leptin enhancing medicinal plants from locally available plants in Pakistan. This study was aimed to see the combined effects of the Leptogenic drug Obesecure on weight management.

Patients of age20 to 50 years with BMI more than 25, not taking any anti-obesity drugs one-month prior to start of study were enrolled. The Participants were randomly allocated to receive either Obesecure or placebo twice a day for three months in Shifa-ul-mulk Hospital, PRIEM Health Care Clinic (Pakistan) and Ria Eastern Medicine Clinic (Pakistan).

An acute toxicity study showed no adverse effect of taking Obesecure prior to clinical trials.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leptin Deficiency Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Multicentre, two arm parallel randomized controlled clinical trial

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Obesecure Capsules (Test Group)

A dose of 500mg capsule twice daily of Polyherbal formulation Obesecure was given in the test group for three months. Short term effectiveness was assessed by BMI calculation on follow up visit after two weeks and long term follow up was assessed by BMI and Leptin Level at three months.

Group Type ACTIVE_COMPARATOR

Leptin Human

Intervention Type DRUG

Plasicure (Control Group)

A dose of 500mg capsule twice daily of Placebo as Plasicure was given in the control group for three months. Short term effectiveness was assessed by BMI calculation on follow up visit after two weeks and long term follow up was assessed by BMI and Leptin Level at three months.

Group Type PLACEBO_COMPARATOR

Leptin Human

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Leptin Human

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Obesecure

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients of age20 to 50 years with BMI more than 25
2. Only those participants were included who were willing
3. Patients of any marital status were included
4. Only those participants were included who did not take any antiobesity drug one-month prior to start of study

Exclusion Criteria

1. Taking an anti-obesity drug in the previous month
2. Pregnant
3. Allergic to laxative drugs
4. Recurrent weight gain history after antiobesity treatment
5. Liver disease
6. Taking hormonal therapy, menopausal women
7. Diabetes mellitus
8. Cardiac problem and hypertension

Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes